Partnership Model

License Our Nanotechnology Platforms

We operate as a B2B enabling technology platform. Pharmaceutical companies license our proprietary nanotechnology to enhance their drug delivery systems—similar to how companies license BASF's enabling materials.

Partnership Process

A structured, milestone-driven process from initial consultation through commercial technology transfer and ongoing support.

01
Week 1-2

Initial Consultation

We begin with a confidential discussion to understand your drug delivery challenges, therapeutic targets, and commercial objectives.

02
Week 3-6

Feasibility Assessment

Our scientific team evaluates the compatibility of your active pharmaceutical ingredients with our nanotechnology platforms and develops a preliminary formulation strategy.

03
Month 2-4

Proof of Concept

Development and testing of prototype formulations demonstrating the performance advantages of our nano-delivery technology with your specific compounds.

04
Month 4-8

Optimization & Validation

Iterative optimization of the formulation followed by comprehensive validation including stability testing, analytical method development, and process characterization.

05
Month 8-12

Technology Transfer & Scale-Up

Complete technology transfer package including manufacturing protocols, quality specifications, and regulatory documentation to support your commercial production.

06
Ongoing

Ongoing Support

Continued technical and regulatory support throughout your product lifecycle, including manufacturing optimization and market expansion assistance.

What We Provide

Comprehensive technology licensing packages designed to enable your success from formulation through commercialization.

Technology Transfer

  • Complete formulation methodology documentation
  • Manufacturing process protocols and parameters
  • Analytical methods and specifications
  • Scale-up guidance for commercial production

Regulatory Support

  • Regulatory strategy development
  • Stability data packages (ICH compliant)
  • Regulatory documentation and compliance guidance
  • Submission support for target markets

Manufacturing Guidance

  • Pharmaceutical-grade production capability
  • Process validation protocols
  • Quality control specifications
  • Supply chain optimization

Partnership Opportunities

We offer flexible partnership structures to meet the specific needs of pharmaceutical companies at various stages of development.

Technology Licensing

License our proprietary nanotechnology platforms for integration into your pharmaceutical products. Includes complete technology transfer, manufacturing protocols, and regulatory support packages.

Platform accessTechnology transferRegulatory documentationManufacturing protocols

Co-Development

Collaborative development partnerships where AGCP works alongside your R&D team to develop custom nano-formulations optimized for your specific therapeutic targets.

Joint developmentShared milestonesCombined expertiseCustomized solutions

Contract Manufacturing

Utilize our production facility for the manufacture of nano-pharmaceutical products developed using our platform technologies.

Pharmaceutical-grade productionQuality assuranceBatch documentationSupply reliability

Strategic Investment

Investment opportunities for venture capital and strategic investors seeking exposure to pharmaceutical nanotechnology with validated platforms and clear commercialization pathways.

Technology portfolioMarket opportunityIP positionGrowth trajectory

Start the Conversation

Whether you're a pharmaceutical company seeking technology licensing, or an investor exploring opportunities in pharmaceutical nanotechnology, we'd welcome the opportunity to discuss how we can work together.